BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Brauneck F, Weimer P, Schulze Zur Wiesch J, Weisel K, Leypoldt L, Vohwinkel G, Fritzsche B, Bokemeyer C, Wellbrock J, Fiedler W. Bone Marrow-Resident Vδ1 T Cells Co-express TIGIT With PD-1, TIM-3 or CD39 in AML and Myeloma. Front Med (Lausanne) 2021;8:763773. [PMID: 34820398 DOI: 10.3389/fmed.2021.763773] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 You H, Zhu H, Zhao Y, Guo J, Gao Q. TIGIT‐expressing zoledronate‐specific γδ T cells display enhanced antitumor activity. J Leukocyte Bio 2022. [DOI: 10.1002/jlb.5ma0822-759r] [Reference Citation Analysis]
2 Huang S, Zhao Y, Liao P, Wang J, Li Z, Tan J, Zha X, Chen S, Li Y, Zhong L. Different expression patterns of VISTA concurrent with PD-1, Tim-3, and TIGIT on T cell subsets in peripheral blood and bone marrow from patients with multiple myeloma. Front Oncol 2022;12. [DOI: 10.3389/fonc.2022.1014904] [Reference Citation Analysis]
3 Iversen KF, Nederby L, Lund T, Plesner T. High Expression of the Costimulatory Checkpoint Factor DNAM-1 by CD4+ T-Cells from Multiple Myeloma Patients Refractory to Daratumumab-Containing Regimens. Clin Hematol Int 2022;4:107-116. [DOI: 10.1007/s44228-022-00013-7] [Reference Citation Analysis]
4 Song Y, Liu Y, Teo HY, Liu H. Targeting Cytokine Signals to Enhance γδT Cell-Based Cancer Immunotherapy. Front Immunol 2022;13:914839. [DOI: 10.3389/fimmu.2022.914839] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Annese T, Tamma R, Ribatti D. Update in TIGIT Immune-Checkpoint Role in Cancer. Front Oncol 2022;12:871085. [PMID: 35656508 DOI: 10.3389/fonc.2022.871085] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
6 Weimer P, Wellbrock J, Sturmheit T, Oliveira-ferrer L, Ding Y, Menzel S, Witt M, Hell L, Schmalfeldt B, Bokemeyer C, Fiedler W, Brauneck F. Tissue-Specific Expression of TIGIT, PD-1, TIM-3, and CD39 by γδ T Cells in Ovarian Cancer. Cells 2022;11:964. [DOI: 10.3390/cells11060964] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]